{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:04:57Z","timestamp":1792184697813,"version":"4.4.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Bone"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.bone.2008.11.006","type":"journal-article","created":{"date-parts":[[2008,11,22]],"date-time":"2008-11-22T05:47:57Z","timestamp":1227332877000},"page":"461-466","source":"Crossref","is-referenced-by-count":32,"title":["Bone turnover and type I collagen C-telopeptide isomerization in adult osteogenesis imperfecta: Associations with collagen gene mutations"],"prefix":"10.1016","volume":"44","author":[{"given":"Patrick","family":"Garnero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Schott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darwin","family":"Prockop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Chevrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bone.2008.11.006_bib1","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jmg.16.2.101","article-title":"Genetic heterogeneity in osteogenesis imperfecta","volume":"16","author":"Sillence","year":"1979","journal-title":"J Med Genet"},{"key":"10.1016\/j.bone.2008.11.006_bib2","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(04)16051-0","article-title":"Osteogenesis imperfecta","volume":"63","author":"Rauch","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.bone.2008.11.006_bib3","first-page":"293","article-title":"Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL 1A1 and COL 1A2","volume":"46","author":"Sykes","year":"1990","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.bone.2008.11.006_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/humu.20429","article-title":"Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans","volume":"28","author":"Marini","year":"2007","journal-title":"Hum Mutat"},{"key":"10.1016\/j.bone.2008.11.006_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1651-2227.1993.tb12554.x","article-title":"Serum concentrations of procollagen I C terminal propeptide, osteocalcin and insulin-like growth factor-I in patients with non-lethal osteogenesis imperfecta","volume":"82","author":"Brenner","year":"1993","journal-title":"Acta Pediatr"},{"key":"10.1016\/j.bone.2008.11.006_bib6","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/0026-0495(94)90220-8","article-title":"Reduced serum levels of carboxy-terminal propeptide of human type I procollagen in a family with type I osteogenesis imperfecta","volume":"43","author":"Minisola","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.bone.2008.11.006_bib7","first-page":"1","article-title":"The mechanical consequences of variation in the mineral content of bone","volume":"2","author":"Currey","year":"1969","journal-title":"J Biochem"},{"key":"10.1016\/j.bone.2008.11.006_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S8756-3282(02)00815-3","article-title":"The contribution of the organic matrix to bone's material properties","volume":"31","author":"Burr","year":"2002","journal-title":"Bone"},{"issue":"suppl 5","key":"10.1016\/j.bone.2008.11.006_bib9","first-page":"S29","article-title":"Role of collagen and other organics in the mechanical properties of bone","volume":"14","author":"Currey","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2008.11.006_bib10","doi-asserted-by":"crossref","first-page":"365S","DOI":"10.1016\/8756-3282(95)00328-B","article-title":"Reduced concentrations of collagen crosslinks are associated with reduced strength of bone","volume":"17","author":"Oxlund","year":"1995","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.11.006_bib11","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1007\/s00198-005-2035-9","article-title":"The role of collagen in bone strength","volume":"17","author":"Viguet-Carrin","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.bone.2008.11.006_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S8756-3282(01)00697-4","article-title":"Age-related changes in collagen network and toughness of bone","volume":"31","author":"Wang","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.11.006_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.bone.2005.07.019","article-title":"Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links","volume":"37","author":"Hernandez","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.11.006_bib14","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/j.bone.2006.05.013","article-title":"Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae","volume":"39","author":"Viguet-Carrin","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.11.006_bib15","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bone.2005.09.014","article-title":"Extracellular post-translational modifications of collagen are major determinants of biomechanical properties of fetal bovine cortical bone","volume":"38","author":"Garnero","year":"2006","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.11.006_bib16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2362.1981.tb01763.x","article-title":"Disorder of collagen metabolism in patients with osteogenesis imperfecta (lethal type). Increased degree of hydroxylation of lysine in type I and III","volume":"11","author":"Kirsch","year":"1981","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.bone.2008.11.006_bib17","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1359\/jbmr.2000.15.7.1330","article-title":"Pyridinium cross-links in bone of patients with osteogenesis imperfecta: evidence of a normal intrafibrillar collagen packing","volume":"15","author":"Bank","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2008.11.006_bib18","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S8756-3282(02)00922-5","article-title":"An immunoassay for type I collagen alpha 1 helicoidal peptide 620\u2013633, a new marker of bone resorption in osteoporosis","volume":"32","author":"Garnero","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.11.006_bib19","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1359\/jbmr.2002.17.5.826","article-title":"Type I collagen racemization and isomerization and the risk of fracture in postmenopausal women: the Ofely study","volume":"17","author":"Garnero","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2008.11.006_bib20","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1359\/JBMR.051015","article-title":"Effects of oral alendronate on BMD in adult patients with osteogenesis imperfecta: a 3-year randomized placebo-controlled trial","volume":"21","author":"Chevrel","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2008.11.006_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00003086-196400330-00010","article-title":"Genetic and environmental factors in the etiology of congenital dislocation of the hip","volume":"33","author":"Carter","year":"1964","journal-title":"Clin Orthop"},{"key":"10.1016\/j.bone.2008.11.006_bib22","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1093\/clinchem\/42.10.1639","article-title":"Coated tube radioimmunoassay for C-telopeptide to assess bone resorption","volume":"42","author":"Bonde","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.bone.2008.11.006_bib23","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1359\/jbmr.1997.12.9.1407","article-title":"Decreased \u03b2 isomerization of the C-terminal telopeptide of type I collagen 1 chain in Paget's Disease of bone","volume":"12","author":"Garnero","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2008.11.006_bib24","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1093\/clinchem\/40.11.2022","article-title":"Immunoassay for quantifying type I collagen degradation products in urine evaluated","volume":"40","author":"Bonde","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.bone.2008.11.006_bib25","doi-asserted-by":"crossref","first-page":"9755","DOI":"10.1074\/jbc.272.15.9755","article-title":"Characterization of urinary degradation products derived from type I collagen: identification of a \u03b2-isomerized aspartyl residue within the C-telopeptide (\u03b11) region","volume":"272","author":"Fledelius","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bone.2008.11.006_bib26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/clinchem\/47.4.694","article-title":"Evaluation of a fully automated serum assay for C-terminal cross-linking telopeptide of type I collagen in osteoporosis","volume":"47","author":"Garnero","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.bone.2008.11.006_bib27","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0076-6879(87)45012-X","article-title":"Analysis of cytoplasma and nuclear messenger RNA in fibroblasts from patients with osteogenesis imperfecta","volume":"145","author":"Genovese","year":"1987","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.bone.2008.11.006_bib28","first-page":"638","article-title":"Osteogenesis imperfecta type I: molecular heterogeneity for COL1A1 null alleles of type I collagen","volume":"55","author":"Willing","year":"1994","journal-title":"Am J Genet"},{"key":"10.1016\/j.bone.2008.11.006_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1056\/NEJM198408093110606","article-title":"Heritable diseases of collagen","volume":"311","author":"Prockop","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/j.bone.2008.11.006_bib30","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1098-1004(1997)9:4<300::AID-HUMU2>3.0.CO;2-9","article-title":"Mutations in fibrillar collagens (types I, II, III and IX), fibril associated collagen (type IX) and network-forming collagen (type X) cause a spectrum of diseases of bone, cartilage and blood vessels","volume":"9","author":"Kuivaniemi","year":"1997","journal-title":"Human Mutat"},{"key":"10.1016\/j.bone.2008.11.006_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s002239900670","article-title":"Osteogenesis imperfecta: bone turnover, bone density and ultrasound parameters","volume":"65","author":"Cepollaro","year":"1999","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/j.bone.2008.11.006_bib32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1373\/clinchem.2006.083055","article-title":"Bone formation markers in adults with mild osteogenesis imperfecta","volume":"59","author":"Cundy","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/j.bone.2008.11.006_bib33","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/j.1651-2227.1998.tb00920.x","article-title":"Collagen derived markers of bone metabolism in osteogenesis imperfecta","volume":"87","author":"Lund","year":"1998","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.bone.2008.11.006_bib34","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.bone.2004.02.023","article-title":"Bone turnover markers in patients with osteogenesis imperfecta","volume":"34","author":"Braga","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.11.006_bib35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/jbmr.5650090706","article-title":"Bone resorption assessed by immunoassay of urinary cross-linked collagen peptides in patients with osteogenesis imperfecta","volume":"9","author":"Brenner","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2008.11.006_bib36","first-page":"224","article-title":"Static and dynamic bone histomorphometry in children with osteogenesis imperfecta","volume":"35","author":"Rauch","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.bone.2008.11.006_bib37","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0169-6009(90)90062-K","article-title":"Normal carboxylation of circulating osteocalcin (bone Gla-protein) in Paget's disease of bone","volume":"11","author":"Merle","year":"1990","journal-title":"Bone Miner"},{"key":"10.1016\/j.bone.2008.11.006_bib38","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1359\/JBMR.041212","article-title":"Non-isomerized C-telopeptide fragments are highly sensitive markers for monitoring disease activity and treatment efficacy in Paget's disease of bone","volume":"20","author":"Alexandersen","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.bone.2008.11.006_bib39","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1359\/jbmr.070505","article-title":"The effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women","volume":"8","author":"Ivaska","year":"2007","journal-title":"J Bone Miner Res"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208008971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328208008971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T14:58:07Z","timestamp":1589122687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328208008971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S8756328208008971"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2008.11.006","relation":{},"ISSN":["8756-3282"],"issn-type":[{"value":"8756-3282","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}